These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 24844782)

  • 81. Howell-jolly body-like inclusions in neutrophils of a transplant recipient in association with ganciclovir therapy.
    Abdel-Monem H; Prakasam A; Thiagarajan P
    Arch Pathol Lab Med; 2010 Jun; 134(6):809-10. PubMed ID: 20524856
    [No Abstract]   [Full Text] [Related]  

  • 82. Howell-Jolly body-like inclusions in the neutrophils of patients with acquired immunodeficiency syndrome.
    Slagel DD; Lager DJ; Dick FR
    Am J Clin Pathol; 1994 Apr; 101(4):429-31. PubMed ID: 8160631
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Antiviral drugs].
    Ruutu P
    Duodecim; 1991; 107(10):779-89. PubMed ID: 1364721
    [No Abstract]   [Full Text] [Related]  

  • 84. Anti-infective therapy for viral pneumonia.
    Mahmood W; Sacks SL
    Semin Respir Infect; 1995 Dec; 10(4):270-81. PubMed ID: 8668855
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Systemic antivirals in herpesvirus infections.
    Sasadeusz JJ; Sacks SL
    Dermatol Clin; 1993 Jan; 11(1):171-85. PubMed ID: 8382122
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Respiratory pharmacology. Antiviral agents.
    Bryson YJ
    Clin Chest Med; 1986 Sep; 7(3):453-67. PubMed ID: 2429801
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Drug resistance in cytomegalovirus: current knowledge and implications for patient management.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 12 Suppl 1():S1-22. PubMed ID: 8680897
    [No Abstract]   [Full Text] [Related]  

  • 88. [Acyclovir and ganciclovir in the treatment of malignant hematological diseases].
    Zhou X; Gan X; Meng P
    Zhonghua Nei Ke Za Zhi; 1997 May; 36(5):349-51. PubMed ID: 10374276
    [No Abstract]   [Full Text] [Related]  

  • 89. Value of animal models to evaluate agents with potential activity against human cytomegalovirus.
    Kern ER
    Transplant Proc; 1991 Jun; 23(3 Suppl 3):152-5, discussion 155. PubMed ID: 1648821
    [No Abstract]   [Full Text] [Related]  

  • 90. [Gastrointestinal cytomegalovirus infections in organ transplant patients].
    Péter A; Telkes G; Varga M; Járay J
    Orv Hetil; 2008 Dec; 149(52):2463-70. PubMed ID: 19087914
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Valganciclovir. Oral treatment of Cytomegalovirus infections].
    Kroes AC
    Ned Tijdschr Geneeskd; 2004 Jun; 148(25):1236-8. PubMed ID: 15301386
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Herpes simplex virus drug-resistance: new mutations and insights.
    Andrei G; Snoeck R
    Curr Opin Infect Dis; 2013 Dec; 26(6):551-60. PubMed ID: 24152761
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Herpes simplex virus resistance to acyclovir: clinical relevance.
    Pottage JC; Kessler HA
    Infect Agents Dis; 1995 Sep; 4(3):115-24. PubMed ID: 8548189
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Howell-Jolly body-like inclusions in immunocompromised patients with antiviral treatment.
    Morales-Indiano C; Arenillas Rocha L; Mas Bosch V; Florensa Brichs L
    Ann Hematol; 2014 Dec; 93(12):2091-2. PubMed ID: 24844782
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 5.